Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Leases: 2019-2021

Historic Leases for Neurocrine Biosciences (NBIX) over the last 3 years, with Sep 2021 value amounting to $97.9 million.

  • Neurocrine Biosciences' Leases rose 37.89% to $97.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $97.9 million, marking a year-over-year increase of 37.89%. This contributed to the annual value of $82.8 million for FY2020, which is 11.44% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Leases of $97.9 million as of Q3 2021, which was down 2.39% from $100.3 million recorded in Q2 2021.
  • Neurocrine Biosciences' Leases' 5-year high stood at $100.3 million during Q2 2021, with a 5-year trough of $49.1 million in Q2 2019.
  • Moreover, its 3-year median value for Leases was $73.3 million (2020), whereas its average is $75.4 million.
  • Data for Neurocrine Biosciences' Leases shows a peak YoY spiked of 48.67% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows Neurocrine Biosciences' Leases stood at $74.3 million in 2019, then rose by 11.44% to $82.8 million in 2020, then soared by 37.89% to $97.9 million in 2021.
  • Its last three reported values are $97.9 million in Q3 2021, $100.3 million for Q2 2021, and $97.0 million during Q1 2021.